Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Breast Neoplasms 60 Neoplasms 59 Lung Neoplasms 32 Prostatic Neoplasms 24 Colorectal Neoplasms 24 Carcinoma, Non-Small-Cell Lung 21 Neoplastic Cells, Circulating 20 Head and Neck Neoplasms 19 Pancreatic Neoplasms 17 Melanoma 14 Ovarian Neoplasms 13 Carcinoma, Hepatocellular 12 Esophageal Neoplasms 10 Colonic Neoplasms 10 Uterine Cervical Neoplasms 9 Liver Neoplasms 9 Glioma 9 Squamous Cell Carcinoma of Head and Neck 8 Multiple Myeloma 8 Leukemia, Myeloid, Acute 8 Sarcoma 7 Neoplasm Metastasis 7 Endometrial Neoplasms 7 Stomach Neoplasms 6 Neoplasm, Residual 6 Myeloproliferative Disorders 6 Leukemia 6 Kidney Neoplasms 6 Gastrointestinal Neoplasms 6 Carcinoma, Renal Cell 6

Interventions

lutetium Lu 177 dotatate 5 Data Collection 3 telotristat ethyl 2 Somatostatin 2 Positron-Emission Tomography 2 Magnetic Resonance Spectroscopy 2 Everolimus 2 Drug Therapy 2 Biopsy 2 surufatinib 1 lanreotide 1 copper dotatate CU-64 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sorafenib 1 Salvage Therapy 1 Radionuclide Imaging 1 Radiomics 1 Radiofrequency Ablation 1 Quality of Life 1 Plastic Surgery Procedures 1 Phlebotomy 1 Patient Reported Outcome Measures 1 Octreotide 1 Molecular Diagnostic Techniques 1 Lutetium-177 1 Lutetium 1 Liver Transplantation 1 Laparoscopy 1 Immunotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neuroendocrine Tumors × Blood Specimen Collection × Clear all

NCT06430021 2026-05-22

PRO-NEM1

Centre Hospitalier Universitaire Dijon

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡